- Home
- APCX vs EVGN Comparison
APCX vs EVGN Comparison
Compare APCX & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- EVGN
- Stock Information
- Founded
- APCX 2006
- EVGN 1999
- Country
- APCX United States
- EVGN Israel
- Employees
- APCX N/A
- EVGN N/A
- Industry
- APCX Finance: Consumer Services
- EVGN Agricultural Chemicals
- Sector
- APCX Finance
- EVGN Industrials
- Exchange
- APCX Nasdaq
- EVGN Nasdaq
- Market Cap
- APCX N/A
- EVGN 9.7M
- IPO Year
- APCX N/A
- EVGN N/A
- Fundamental
- Price
- APCX $0.60
- EVGN $1.35
- Analyst Decision
- APCX
- EVGN Strong Buy
- Analyst Count
- APCX 0
- EVGN 1
- Target Price
- APCX N/A
- EVGN $12.00
- AVG Volume (30 Days)
- APCX 10.6M
- EVGN 58.6K
- Earning Date
- APCX 11-14-2024
- EVGN 11-21-2024
- Dividend Yield
- APCX N/A
- EVGN N/A
- EPS Growth
- APCX N/A
- EVGN N/A
- EPS
- APCX N/A
- EVGN N/A
- Revenue
- APCX $365,000.00
- EVGN $7,478,000.00
- Revenue This Year
- APCX $1,315.48
- EVGN $90.35
- Revenue Next Year
- APCX N/A
- EVGN $38.71
- P/E Ratio
- APCX N/A
- EVGN N/A
- Revenue Growth
- APCX N/A
- EVGN 30.69
- 52 Week Low
- APCX $0.31
- EVGN $1.20
- 52 Week High
- APCX $2.30
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- APCX 60.21
- EVGN 36.47
- Support Level
- APCX $0.36
- EVGN $1.20
- Resistance Level
- APCX $1.49
- EVGN $1.49
- Average True Range (ATR)
- APCX 0.14
- EVGN 0.12
- MACD
- APCX 0.02
- EVGN 0.01
- Stochastic Oscillator
- APCX 24.32
- EVGN 35.71
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.